LU85952A1 - Nouveaux composes hemiacetaliques et leurs applications - Google Patents

Nouveaux composes hemiacetaliques et leurs applications Download PDF

Info

Publication number
LU85952A1
LU85952A1 LU85952A LU85952A LU85952A1 LU 85952 A1 LU85952 A1 LU 85952A1 LU 85952 A LU85952 A LU 85952A LU 85952 A LU85952 A LU 85952A LU 85952 A1 LU85952 A1 LU 85952A1
Authority
LU
Luxembourg
Prior art keywords
formula
hemiacetal
compounds
liposomes
mixture
Prior art date
Application number
LU85952A
Other languages
English (en)
French (fr)
Inventor
Henri Sebag
Guy Vanlerberghe
Alexandre Zysman
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Priority to LU85952A priority Critical patent/LU85952A1/fr
Priority to FR8608514A priority patent/FR2586017B1/fr
Priority to GB8614435A priority patent/GB2176481B/en
Priority to US06/874,006 priority patent/US4827003A/en
Priority to DE19863619883 priority patent/DE3619883A1/de
Publication of LU85952A1 publication Critical patent/LU85952A1/fr
Priority to US07/340,754 priority patent/US5008406A/en
Priority to GB8911935A priority patent/GB2218096B/en
Priority to GB8921735A priority patent/GB2221682B/en
Priority to GB8921736A priority patent/GB2221683A/en
Priority to US07/654,517 priority patent/US5164488A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
    • A61K47/6911—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a liposome
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/12—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/10—Saturated ethers of polyhydroxy compounds
    • C07C43/11—Polyethers containing —O—(C—C—O—)n units with ≤ 2 n≤ 10
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/13—Saturated ethers containing hydroxy or O-metal groups
    • C07C43/135—Saturated ethers containing hydroxy or O-metal groups having more than one ether bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/178—Unsaturated ethers containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/04—Seven-membered rings not condensed with other rings
    • C07D321/08—1,4-Dioxepines; Hydrogenated 1,4-dioxepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/812—Liposome comprising an antibody, antibody fragment, antigen, or other specific or nonspecific immunoeffector
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU85952A 1985-06-14 1985-06-14 Nouveaux composes hemiacetaliques et leurs applications LU85952A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
LU85952A LU85952A1 (fr) 1985-06-14 1985-06-14 Nouveaux composes hemiacetaliques et leurs applications
FR8608514A FR2586017B1 (fr) 1985-06-14 1986-06-12 Nouveaux composes hemiacetaliques et leurs applications
GB8614435A GB2176481B (en) 1985-06-14 1986-06-13 New hemiacetal compounds
US06/874,006 US4827003A (en) 1985-06-14 1986-06-13 Hemiacetal compounds and the applications thereof
DE19863619883 DE3619883A1 (de) 1985-06-14 1986-06-13 Hemiacetal-verbindungen, verfahren zu deren herstellung und anwendungsverfahren
US07/340,754 US5008406A (en) 1985-06-14 1989-04-20 Hemiacetal compounds and the applications thereof
GB8911935A GB2218096B (en) 1985-06-14 1989-05-24 Hydroxy ether compounds
GB8921735A GB2221682B (en) 1985-06-14 1989-09-27 New dithioacetal compounds
GB8921736A GB2221683A (en) 1985-06-14 1989-09-27 New alcohol compounds
US07/654,517 US5164488A (en) 1985-06-14 1991-02-13 New hemiacetal compounds and the applications thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU85952 1985-06-14
LU85952A LU85952A1 (fr) 1985-06-14 1985-06-14 Nouveaux composes hemiacetaliques et leurs applications

Publications (1)

Publication Number Publication Date
LU85952A1 true LU85952A1 (fr) 1987-01-13

Family

ID=19730488

Family Applications (1)

Application Number Title Priority Date Filing Date
LU85952A LU85952A1 (fr) 1985-06-14 1985-06-14 Nouveaux composes hemiacetaliques et leurs applications

Country Status (5)

Country Link
US (3) US4827003A (de)
DE (1) DE3619883A1 (de)
FR (1) FR2586017B1 (de)
GB (3) GB2176481B (de)
LU (1) LU85952A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85952A1 (fr) * 1985-06-14 1987-01-13 Oreal Nouveaux composes hemiacetaliques et leurs applications
US4976953A (en) * 1987-03-06 1990-12-11 The Procter & Gamble Company Skin conditioning/cleansing compositions containing propoxylated glycerol derivatives
FR2623716B1 (fr) * 1987-11-27 1991-04-05 Lvmh Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant de la tyrosine ou un derive de tyrosine et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite pigmentante, l'incorporant
US5290562A (en) * 1987-11-27 1994-03-01 L V M H Recherche Compositions and methods employing liposomes including tyrosine or a tyrosine derivative
US6372249B1 (en) 1991-12-16 2002-04-16 Baylor College Of Medicine Senscent cell-derived inhibitors of DNA synthesis
FR2694289B1 (fr) * 1992-07-29 1994-10-14 Oreal Composés amphiphiles soufrés, fluorés et polyglycérolés, composition cosmétique ou pharmaceutique en comportant, procédé de préparation et vésicules formées.
DE4312656C2 (de) * 1993-04-19 1996-01-25 Beiersdorf Ag Kühlend wirkende kosmetische oder dermatologische Zusammensetzungen
DE69427251T2 (de) * 1993-07-27 2001-10-31 Terumo Corp Verabreichungssystem für Arzneistoffe
WO1996012716A1 (en) * 1994-10-22 1996-05-02 Chong Kun Dang Corp. Nucleoside derivatives and process for preparing thereof
JP2000506121A (ja) 1996-02-16 2000-05-23 マツクス―プランク―ゲゼルシヤフト ツール フエルデルング デル ヴイツセンシヤフテン エー フアウ ホスファチジルオリゴグリセリン
DE19622224A1 (de) 1996-02-16 1997-08-21 Max Planck Gesellschaft Phosphatidyloligoglycerine
DE19748796A1 (de) * 1997-11-05 1999-05-06 Beiersdorf Ag Verfahren zur Herstellung von Liposomen
DE19835611A1 (de) 1998-08-06 2000-02-10 Max Planck Gesellschaft Neuartige Phospholipide mit synthetischen, ungesättigten Alkyl- und Acylketten
WO2004110614A1 (en) * 2003-06-13 2004-12-23 Dsm Ip Assets B.V. Encapsulated materials
US20080031909A1 (en) * 2004-12-10 2008-02-07 Dsm Ip Assets B.V. Encapsulated Cosmetic Materials
US8623344B2 (en) * 2007-06-29 2014-01-07 Mcneil-Ppc, Inc. Structured depilatory compositions
US20090304589A1 (en) * 2007-09-28 2009-12-10 Varian Medical Systems,Inc. Radiation sensitive liposomes
JP5270188B2 (ja) * 2008-02-22 2013-08-21 株式会社クラレ 新規なアクリル酸エステル誘導体、高分子化合物
CN105218511B (zh) * 2015-10-12 2017-07-14 太原理工大学 一种脂肪醛缩甘油磺基琥珀酸单酯盐及其制备工艺
KR101917854B1 (ko) * 2017-08-24 2018-11-12 한국콜마주식회사 세포 수용체 결합능이 있는 펩티드를 포함하는 마이크로 캡슐 및 이를 포함하는 화장료 조성물

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US32084A (en) * 1861-04-16 Improvement in corn-planters
GB443559A (en) * 1934-06-15 1936-02-17 Ig Farbenindustrie Ag Improvements in the manufacture and production of valuable watersoluble condensationproducts suitable as assistants in the textile and related industries
US2418297A (en) * 1944-01-04 1947-04-01 Shell Dev Substituted dioxanes
US3427248A (en) * 1965-10-22 1969-02-11 Lever Brothers Ltd Detergent
GB1270579A (en) * 1968-08-17 1972-04-12 Fuji Photo Film Co Ltd Dihydroxy-1,4-dioxanes
DE2522287C2 (de) * 1975-05-20 1981-09-24 Degussa Ag, 6000 Frankfurt Mittel zur antistatischen Ausrüstung von thermoplastischen Kunststoffen
FR2315991A1 (fr) 1975-06-30 1977-01-28 Oreal Procede de fabrication de dispersions aqueuses de spherules lipidiques et nouvelles compositions correspondantes
DE2631030A1 (de) * 1976-07-09 1978-01-12 Bayer Ag Kationische farbstoffe
USRE32084E (en) 1976-09-17 1986-02-18 National Distillers And Chemical Corporation Glycol aldehyde and ethylene glycol processes
CA1157774A (en) * 1980-07-30 1983-11-29 Anthony Cerami Method for the reduction of mucin viscosity
JPS57197236A (en) * 1981-05-28 1982-12-03 Kao Corp 2-hydroxy-3-methyl branched alkoxypropyl glyceryl ether and cosmetic containing the same
EP0094586A3 (de) * 1982-05-13 1984-06-06 Ono Pharmaceutical Co., Ltd. Glycerol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
LU85952A1 (fr) * 1985-06-14 1987-01-13 Oreal Nouveaux composes hemiacetaliques et leurs applications

Also Published As

Publication number Publication date
FR2586017B1 (fr) 1988-03-25
GB2221683A (en) 1990-02-14
GB2218096B (en) 1990-04-04
FR2586017A1 (fr) 1987-02-13
US4827003A (en) 1989-05-02
US5164488A (en) 1992-11-17
US5008406A (en) 1991-04-16
GB8614435D0 (en) 1986-07-16
GB2218096A (en) 1989-11-08
DE3619883A1 (de) 1986-12-18
GB2176481A (en) 1986-12-31
GB8921736D0 (en) 1989-11-08
GB8911935D0 (en) 1989-07-12
GB2176481B (en) 1989-07-19

Similar Documents

Publication Publication Date Title
LU85952A1 (fr) Nouveaux composes hemiacetaliques et leurs applications
EP1644318B1 (de) Verfahren zur synthese von verbindungen vom ceramidtyp
CA1183168A (fr) Tensio-actifs non ioniques, leur procede de preparatin et composition
CA2025790C (fr) Nouveaux composes lipidiques derives des sphingosines, leur procede de preparation et leurs applications, notamment en cosmetique et en dermopharmacie
CA1266860A (fr) Composes lipidiques amphiphiles, leur procede de preparation et leurs applications, notamment en cosmetique et en dermopharmacie
FR2694934A1 (fr) Composition pour le traitement de l'acné contenant un dérivé d'acide salicylique et dérivés d'acide salicylique.
FR2808691A1 (fr) Cyclodextrines substituees preferentiellement sur leur face primaire par des fonctions acide ou amine
EP0664290A1 (de) Zimtsäure mono- und di-Ester oder Ester von Derivaten und Vitamin C, Verfahren zu deren Herstellung und deren Verwendung als Antioxidantien in kosmetischen, pharmazeutischen oder Nahrungszusammensetzungen
CA1167070A (fr) Nouveaux agents de surface non-ioniques polyoxyethylenes a deux chaines lipophiles, leur procede de preparation et compositions les contenant
FR2765873A1 (fr) Derives non ioniques de vitamine e et procede de preparation de ceux-ci, et vesicules de polymeres amphiphiles formees a partir de ceux-ci
FR2694289A1 (fr) Composés amphiphiles soufrés, fluorés et polyglycérolés, composition cosmétique ou pharmaceutique en comportant, procédé de préparation et vésicules formées.
FR2549826A1 (fr) Nouveaux ethers de polyols, leur procede de preparation et leur application en cosmetique
FR2492829A1 (fr) Agents de surface non-ioniques derives du glucose, procede pour les preparer et compositions les contenant
FR2482128A1 (fr) Nouveaux tensio-actifs non ioniques, leur procede de preparation et composition les contenant
FR2808275A1 (fr) Composes de type ceramide ayant une propreite antioxydante, procede pour leur preparation, et composition cosmetique les contenant
CA2276902A1 (fr) Compositions cosmetiques, nouveaux analogues de ceramides a activite anti-elastase, procede de preparation et utilisations
FR2741079A1 (fr) Nouveaux composes, derives de cyclodextrine et leur utilisation, notamment en cosmetique
EP1737495A1 (de) Neue pharmazeutische oder kosmetische träger mit cyclischen acetalen
EP0946516B1 (de) Neue histidinderivate, verfahren zu ihrer herstellung und ihre verwendung als mittel gegen freie radikale
FR2701478A1 (fr) Dérivés de vitamine E contenant de l'azote quaternaire et procédés pour leur préparation.
FR2681868A1 (fr) Nouvelles substances amphiphiles derivees de cyclodextrines et leur utilisation dans des compositions cosmetiques.
LU85420A1 (fr) Composes anioniques a deux chaines grasses et compositions les contenant
CA2158723A1 (fr) Composes fluores, leur preparation, leur utilisation, les milieux et les compositions les comprenant
WO1999015147A2 (fr) Utilisation d'alkyl monoglucosides en tant que vecteurs moleculaires
FR2980694A1 (fr) Agent emulsifiant, procede de fabrication, et utilisation